Risk Assessment in Chronic Myelomonocytic Leukemia (CMML)

Reference

• Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R. and Sultan, C. (1982) "Proposals for the classification of the myelodysplastic syndromes", British Journal of Haematology, 51, 189–199.
   PubMed Web of Science ®Google Scholar
• Aul, C., Gattermann, N. and Schneider, W. (1995) "Epidemiolo-gical and etiological aspects of myelodysplastic syndromes", Leukemia and Lymphoma, 16, 247 — 262.
   PubMed Web of Science ®Google Scholar
• Germing, U., Gattermann, N., Minning, H., Heyll, A. and Aul, C. (1998) "Problems in the classification of CMML. Dysplastic vs. proliferative type", Leukemia Research, 22, 871–878.
   PubMed Web of Science ®Google Scholar
• Michaux, J.L. and Martiat, P. (1993) "Chronic myelomonocytic leukaemia (CMML). A myelodysplastic or myeloproliferative syndrome?", Leukemia and Lymphoma, 9, 35–41.
   PubMed Web of Science ®Google Scholar
• Strupp, C., Germing, U., Trommer, I., Gattermann, N. and Aul, C. (2000) "Pericardial effusion in chronic myelomonocytic leukemia", Leukemia Research, 24, 1059 — 1062.
   PubMed Web of Science ®Google Scholar
• Duguid, J.K., Maclde, M.J. and McVerry, B.A. (1983) "Skin infiltration associated with chronic myelomonocytic leukaemia", British Journal of Haematology, 53, 257— 264.
   Google Scholar
• Voglova, J., Chrobak, L., Neuwirtova, R., Malaskova, V. and Straka, L. (2001) "Myelodysplastic and myeloproliferative type of chronic myelomonocytic leukemia", Leukemia Research, 25, 493–499.
   PubMed Web of Science ®Google Scholar
• Aul, C., Gattermann, N., Germing, U., Stidhoff, T., Hollmig, K.A. and Heyll, A. (1997) "Fatal hyperleukocytic syndrome in a patient with chronic myelomonocytic leukemia", Leukemia Research, 21, 249 — 253.
   Google Scholar
• Cervera, J., Sanz, G.F., Vallespie, T., del Canizo, MC., Irriguible, D., Lopez, F., et al. (1997) "Does WBC really define two different subtypes of chronic myelomonocytic leukemia (CMML)? Analysis of a series of 119 patients", Leukemia Research, 21\(Suppl 1), P27.
   Google Scholar
• Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R., et al. (1994) "The chronic myeloid leukemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia group", British Journal of Haematology, 87, 746–754.
   Google Scholar
• Harris, N.L., Jaffe, ES., Diebold, J., Flandrin, G., Muller-Hermelink, H.K., et al. (1999) "WHO classification of neoplastic diseases of the hematopoietic and lymphoid tissues", Journal of Clinical Oncology, 17, 3835–3849.
   PubMed Web of Science ®Google Scholar
• Bennett, J.M. (2000) "WHO-Classification of the acute leukemias and myelodysplastic syndromes", International Journal of Hematol-ogy, 72, 131–133.
   Google Scholar
• Padua, R.A., Guinn, B.A., Al-Sabah, AT., Smith, M., Taylor, C., Pettersson, T., et al. (1998) "RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias", Leukemia, 12, 878–892.
   Web of Science ®Google Scholar
• Pitini, V., Arrigo, C., Teti, D., Barresi, G., Righi, M. and Alo, G. (2003) "Response to STI571 in chronic myelomonocytic leukemia with platelet derived growth factor beta receptor involvement", Haematologica, 88, 5.
   Google Scholar
• Fenawc, P., Beuscart, R., Lai, J.L., Jouet, J.P. and Bauters, F. (1988) "Prognostic factors in adult chronic myelomonocytic leukemia: an analysis of 107 cases", Journal of Clinical Oncology, 6, 1417–1424.
   PubMed Web of Science ®Google Scholar
• Tefferi, A., Hoagland, H.C., Therneau, T.M. and Pierre, R.V. (1989) "Chronic myelomonocytic leukemia: Natural history and prognostic determinance", Mayo Clinic Procedures, 64, 1246–1254.
   PubMed Web of Science ®Google Scholar
• Onida, F., Kantarijan, H.M., Smith, T.L., Ball, G., Keating, M.J., Estey, E.H., et al. (2002) "Prognostic factors in scoring system in chronic myelomonocytic leukemia", Blood, 99, 840–849.
   Google Scholar
• Goasguen, J.E., Garand, R., Bizet, M., et al. (1990) "Prognostic factors of myelodysplastic syndromes. A simplified 3-D scoring system", Leukemia Research, 14, 255–262.
   PubMed Web of Science ®Google Scholar
• Solal-Celigny, P., Desaint, B., Herrera, A., Chastang, C., Amar, M., Vroclans, M., et al. (1984) "Chronic myelomoncytic leukemia according to FAB classification: analysis of 35 cases", Blood, 63, 634 —638.
   PubMed Web of Science ®Google Scholar
• Germing, U., Strupp, C., Aivado, M. and Gattermann, N. (2000) "New prognostic parameters for chronic myelomonocytic leuke-mia?" Blood, 100, 731 — 733.
   Google Scholar
• Ribera, J.M., Cervantes, F. and Rozman, C. (1987) "A multivariate analysis of prognostic factors in chronic myelomonocytic leukaemia according to the FAB criteria", British Journal of Haematology, 65, 307 —311.
   Google Scholar
• Groupe Francais de Cytogenetique Hematologique (1991) "Chronic myelomonocytic leukaemia: Single entity or heterogeneous dis-order? A prospective multicenter study of 100 patients", Cancer Genetics Cytogenetics, 55, 57–65.
   Google Scholar
• Catalano, L., Improta, S., de Laurentiis, M., Molica, S., Majolino, I., Musto, P., et al. (1996) "Prognosis of chronic myelomonocytic leukemia", Haematologica, 81, 324–329.
   PubMed Web of Science ®Google Scholar
• Worsley, A., Oscier, D.G., Stevens, J., et al. (1988) "Prognostic features of chronic myelomonocytic leukaemia: a modified Bourne-mouth score gives the best prediction of survival", British Journal of Haematology, 68, 17 — 21.
   Google Scholar
• Stark, A.N., Thorogod, J., Head, C., Roberts, B.E. and Scott, C.S. (1987) "Prognostic factors and survival in chronic myelomonocytic leukaemia (CMML)", British Journal of Cancer, 56, 59 — 63.
   Google Scholar
• Nösslinger, T., Reisner, R., Griiner, H., Tfichler, H., Nowotny, H., Pittermann, E. and Pfeilstöcker, M. (2001) "Dysplastic versus proliferative CMML", Leukemia Research, 25, 741–747.
   PubMed Web of Science ®Google Scholar
• Gonzales-Medina, I., Bueno, J., Torrequebrada, A., Lopez, A., Vallespi, T. and Massague, I. (2002) "Two groups of chronic myelomonocytic leukaemia: myelodysplastic and myeloprolifera-tive. Prognostic implications in a series of a single center", Leukemia Research, 26, 821 — 824.
   Google Scholar
• Aul, C., Gattermann, N., Germing, U., Winkelmann, M., Heyll, A., Runde, V., et al. (1994) "Serum deoxythymidine lcinase in myelodysplastic syndromes", Cancer, 73, 322— 327.
   Google Scholar
• Germing, U., Gattermann, N., Strupp, C., Aivado, M., Haas, R. and Aul, C. (2000) "Validation of the WHO proposals for the classification of myelodysplastic syndromes. A retrospective analysis of 1600 cases", Leukemia Research, 24, 983–992.
   PubMed Web of Science ®Google Scholar
• Molica, S., Iannaccaro, P. and Albeti, A. (1990) "Chronic myelomonocytic leukemia: A test of a proposed staging system", American Journal of Haematology, 35, 129 — 130.
   Google Scholar
• Aul, C., Gattermann, N., Heyll, A., Germing, U., Derigs, G. and Schneider, W. (1992) "Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system", Leukemia, 6, 52— 59.
   Google Scholar
• Greenberg, P., Cox, C., LeBeau, MM., Fenawc, P., Morel, P., Sanz, G., et al. (1997) "International scoring system for evaluating prognosis in myelodysplastic syndromes", Blood, 89, 2079 — 2088.
   Google Scholar
• del Canizo, MC., Sanz, G., San Miguel, J.F., et al. (1989) "Chronic myelomonocytic leukemia—clinicobiological characteristics: a mul-tivariate analysis in a series of 70 cases", European Journal of Haematology, 42, 466–473.
   Google Scholar
• Au!, C., Gattermann, N., Germing, U., Runde, V., Heyll, A. and Schneider, W. (1994) "Risk assessment in primary myelodysplastic syndromes: validation of the Dusseldorf Score", Leukemia, 8, 1906–1913.
   PubMed Web of Science ®Google Scholar
• Kerkhofs, H., Hermanns, J., Haak, H.L. and Leeksma, H.W. (1987) "Utility of the FAB classification for myelodysplastic syndromes: Investigation of prognostic factors in 237 cases", British Journal Haematology, 65, 73–81.
   PubMed Web of Science ®Google Scholar
• Sanz, G.F., Sanz, M.A., Vallespie, T., Canizo, M.C., Torrabadella, M., Garcia, S., et al. (1989) "Two regression models and a scoring system for predicting survival and planning treatment in myelodys-plastic syndromes: a multivariate analysis of prognostic factors in 370 patients", Blood, 74, 395 —408.
   Google Scholar
• Storniolo, A.M., Moloney, W.C., Rosenthal, D.S., Cox, C., Bennett, J.M. (1990) "Chronic myelomonocytic leukemia", Leuke-mia, 4, 766–770.
   PubMed Web of Science ®Google Scholar